Scott E. Norris

FDA investigator

Appears on 3 documents from 2017 to 2019, most often at sites in France. Most often cites production record review (21 CFR 211.192).

3
Documents on file
6.7
Observations per 483
2017
First seen
2019
Most recent

What they cite most

From 20 observations

Activity by year

2017: 1, 2018: 1, 2019: 1

Where

France 1 · Ireland 1 · North Carolina 1

Is Scott E. Norris coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

3 documents, newest first
FirmOpen
483 Wyeth Pharmaceutical Division of Wyeth Holdings LLCNov 26, 2019 · Sanford, North Carolina
483 Pfizer Ireland Pharmaceuticals Unlimited CompanySep 18, 2018 · Dublin, Ireland
483 Sanofi Winthrop IndustrieSep 27, 2017 · Marcy L Etoile, France

About this profile

What does Scott E. Norris inspect?

Scott E. Norris appears on 3 documents on file covering 3 sites, most often in France.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.160 and 21 CFR 211.68.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Scott E. Norris is dated Nov 26, 2019.

FDA Investigator Scott E. Norris: 483s & Inspections · FDA Intel